Is Arch Therapeutics, Inc. (ARTH) a Buy, Sell, or Hold?
OTC : ARTH
Arch Therapeutics, Inc.
$0.0001 USD
$0.0 (0.0%)
- Volume
- 1
- Average Volume
- 2.12K
- Market Capitalization
- $444
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.57
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.21
Company Overview
OTC
Terrence W. Norchi
Biotechnology
Healthcare
ARTH
8
US
USD
Liquidity Metrics
-0.75
0.21
0.06
0.02
0.00
Sales & Valuation
$75724
0.01
0.00
0.00
-1.10
Profitability
-$2.27
-$6.98M
-9221.43%
-9221.43%
119.36%
-356.60%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
3 Analysts
%
Financial Health Scores
-103.90
3/9
-$12.57M
$1.4M
$13.96M
-$8.68M
Key Metrics (TTM)
$5.41M
71.38
-1.39
0.21
119.36%
268.33%
-2271494.72%
-760976.80%
-4388 days
Company Executives
| Name | Title |
|---|---|
| Rutledge Ellis-Behnke | Co-Founder & Scientific Advisor |
| Terrence W. Norchi | Co-Founder, Chairman, President, Chief Executive Officer, Principal Accounting Officer & Treasurer |
| Shawn Carlson | Vice President of Sales |
Poll Results
No votes yet today — be the first to share your view!
About Arch Therapeutics, Inc. (OTC:ARTH) Stock
Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts. ...
Frequently Asked Questions
-
What is the current Arch Therapeutics, Inc. (ARTH) stock price?
-
Arch Therapeutics, Inc.(OTC:ARTH) stock price is $0.0001 in the last trading session. During the trading session, ARTH stock reached the peak price of $1.567 while $0.0001 was the lowest point it dropped to. The percentage change in ARTH stock occurred in the recent session was 0.0% while the dollar amount for the price change in ARTH stock was $0.0.
-
ARTH's industry and sector of operation?
-
The OTC listed ARTH is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ARTH?
-
Rutledge Ellis-Behnke | Co-Founder & Scientific Advisor
Terrence W. Norchi | Co-Founder, Chairman, President, Chief Executive Officer, Principal Accounting Officer & Treasurer
Shawn Carlson | Vice President of Sales
|
| -
How many employees does ARTH have?
-
Number of ARTH employees currently stands at 8. ARTH operates from 235 Walnut Street, Framingham, MA 01702, US.
-
Link for ARTH official website?
-
Official Website of ARTH is: https://www.archtherapeutics.com
-
How do I contact ARTH?
-
ARTH could be contacted at phone #617 431 2313 and can also be accessed through its website. ARTH operates from 235 Walnut Street, Framingham, MA 01702, US.
-
How many shares of ARTH are traded daily?
-
The average number of ARTH shares traded daily for last 3 months was 2.12K.
-
What is the market cap of ARTH currently?
-
The market value of ARTH currently stands at $444 with its latest stock price at $0.0001